Industry News

June 18, 2013

Booming Alexion breaks ground on $140M global HQ

June 18, 2013

Adamas claims success with new and improved Parkinson’s drug

June 18, 2013

R&D cutbacks loom at Millennium's Cambridge ops

June 18, 2013

Teva Pharma breaks M&A silence with bite-sized MicroDose buyout

June 18, 2013

Analysis: Big Pharma R&D demonstrates a woeful lack of innovation

June 18, 2013

Buzz on rare disease drugs puts ViroPharma in the M&A spotlight

June 18, 2013

Royalty's $8B offer wilts after Elan prevails in blocking bid

June 18, 2013

AstraZeneca picks Cambridge site as ground zero for R&D reinvention

June 17, 2013

Onconova files $75M IPO as new offerings sizzle

June 17, 2013

Eli Lilly wraps $247M deal for PhII diabetes drug